| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 11.68B | 13.72B | 13.48B | 13.01B | 17.36B |
| Gross Profit | 4.00B | 3.96B | 3.69B | 3.31B | 3.81B |
| EBITDA | 3.45B | 2.94B | 3.39B | 3.11B | 4.12B |
| Net Income | 667.86M | 690.21M | 728.59M | 345.27M | 923.12M |
Balance Sheet | |||||
| Total Assets | 41.17B | 40.67B | 40.62B | 42.21B | 46.30B |
| Cash, Cash Equivalents and Short-Term Investments | 6.65B | 6.87B | 6.41B | 7.96B | 9.00B |
| Total Debt | 4.75B | 5.32B | 6.30B | 8.68B | 10.96B |
| Total Liabilities | 9.53B | 10.02B | 10.34B | 12.56B | 15.77B |
| Stockholders Equity | 14.52B | 13.76B | 13.61B | 13.24B | 14.44B |
Cash Flow | |||||
| Free Cash Flow | 1.43B | 2.09B | 1.67B | 1.66B | 2.39B |
| Operating Cash Flow | 2.95B | 3.16B | 2.85B | 3.01B | 3.53B |
| Investing Cash Flow | -1.75B | -587.60M | -822.54M | 611.83M | -1.17B |
| Financing Cash Flow | -1.62B | -1.90B | -3.56B | -2.67B | -2.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$63.11B | 7.14 | 11.78% | 5.34% | 1.02% | 0.36% | |
75 Outperform | HK$21.15B | 6.93 | 8.00% | 3.47% | 6.08% | 5.81% | |
73 Outperform | HK$65.07B | 9.77 | 5.92% | 5.72% | 12.77% | -18.46% | |
69 Neutral | HK$4.30B | 6.18 | 4.48% | 6.69% | -14.81% | -3.39% | |
67 Neutral | HK$21.54B | 7.64 | 5.04% | 4.97% | 10.25% | -9.65% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | HK$39.05B | 9.45 | 3.25% | 3.23% | 8.66% | 53.27% |